Zur Seitenansicht
 

Titelaufnahme

Titel
The influence of recombinant production on the immunologic behavior of birch pollen isoallergens
VerfasserWallner, Michael ; Himly, Martin ; Neubauer, Angela ; Erler, Anja ; Hauser, Michael ; Asam, Claudia ; Mutschlechner, Sonja ; Ebner, Christof ; Briza, Peter ; Ferreira, Fatima
Erschienen in
PLoS ONE, Lawrence, Kan., 2009, Jg. 4, S. 1-8
ErschienenPublic Library of Science, 2009
SpracheEnglisch
DokumenttypAufsatz in einer Zeitschrift
Schlagwörter (EN)Recombinant proteins / Allergens / Pollen / Sodium phosphate / Recombinant protein purification / Basophils / Hydrophobic interaction chromatography / Protein structure
ISSN1932-6203
URNurn:nbn:at:at-ubs:3-5882 Persistent Identifier (URN)
DOI10.1371/journal.pone.0008457 
Zugriffsbeschränkung
 Das Werk ist frei verfügbar
Dateien
The influence of recombinant production on the immunologic behavior of birch pollen isoallergens [0.53 mb]
Links
Nachweis
Klassifikation
Zusammenfassung (Englisch)

Background: Allergic reactions towards the birch major pollen allergen Bet v 1 are among the most common causes of spring pollinosis in the temperate climate zone of the Northern hemisphere. Natural Bet v 1 is composed of a complex mixture of different isoforms. Detailed analysis of recombinant Bet v 1 isoforms revealed striking differences in immunologic as well as allergenic properties of the molecules, leading to a classification of Bet v 1 isoforms into high, medium, and low IgE binding proteins. Especially low IgE binding Bet v 1 isoforms have been described as ideal candidates for desensitizing allergic patients with allergen specific immunotherapy (SIT). Since diagnosis and therapy of allergic diseases are highly dependent on recombinant proteins, continuous improvement of protein production is an absolute necessity. Methodology: Therefore, two different methods for recombinant production of a low IgE binding Bet v 1 isoform were applied; one based on published protocols, the other by implementing latest innovations in protein production. Both batches of Bet v 1.0401 were extensively characterized by an array of physicochemical as well as immunological methods to compare protein primary structure, purity, quantity, folding, aggregation state, thermal stability, and antibody binding capacity. Conclusion: The experiments demonstrated that IgE antibody binding properties of recombinant isoallergens can be significantly influenced by the production method directly affecting possible clinical applications of the molecules.